Members of our team had the opportunity to present a new poster abstract at the ASHP 2023 Midyear Clinical Meeting held December 3-7.

Background

• Poor blood glycemic control in humans can cause many deleterious effects, including infection, renal disease, and death.
• Individuals with a history of hospitalization for major mental illness have an estimated 1.5-to 2.5-fold increased risk for developing type II diabetes with subsequent sequalae.
• Behavioral health hospitals present a unique opportunity for pharmacist interventions in the management of insulin therapy due to serving a high-risk patient demographic coupled with continuity of care challenges.
• The Montana State Hospital is a 270-bed state run inpatient behavioral health hospital that facilitates the acute and chronic treatment of mental illness to both civil and forensic patient populations.

Objectives

The objective of this study is to evaluate the effectiveness of a pharmacist-led insulin management program to improve and sustain appropriate blood glycemic control in an inpatient behavioral health hospital.

Read about the team's findings by downloading the Outcomes Study below.

Download the abstract: